PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
27-Aug-2024 UCB to Accelerate Innovation and Strategic Partnerships, Divesting Mature Product Portfolio in China UCB
27-Aug-2024 New LiverAdvocates.org Website Launches With Fatty Liver Risk Assessment Quiz Newswire
27-Aug-2024 First-of-Its-Kind Study Characterizing the Mechanism of Template Switching With Ultraprocessive Reverse Transcriptase Enzymes Newswire
26-Aug-2024 MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study Newswire
23-Aug-2024 Asthma + Lung UK and Sanofi join forces to empower healthcare professionals to improve health outcomes for people with COPD Asthma + Lung UK  
22-Aug-2024 In Pursuit of Excellence: State of the Art Electronic Consent for Clinical Trials Newswire
22-Aug-2024 DATA SUPPORTING FDA APPROVAL PUBLISHED IN HIGH-IMPACT JOURNAL ANGLE plc
22-Aug-2024 Unaudited Interim Results for the six months ended 30 June 2024 Cambridge Cognition Holdings plc
22-Aug-2024 Breaking down barriers DeSci Labs
22-Aug-2024 Kelso Pharma appoints first Director of Corporate Development as international expansion continues Kelso Pharma
20-Aug-2024 Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs Newswire
20-Aug-2024 The Programmable Logic Controller (PLC) Market is predicted to reach USD 22 billion with a CAGR of 6% by 2030 Next Move Strategy Consulting
19-Aug-2024 MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End Newswire
19-Aug-2024 Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi™ and FDA Accepts Biosimilar Biologics License Application for TX-05 Newswire
19-Aug-2024 uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy Newswire
16-Aug-2024 New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain Astellas Pharma Ltd
16-Aug-2024 Peptide-ExplorerLT launched by Vapourtec ...aimed at chemists looking to explore and optimise linear peptide synthesis Vapourtec
16-Aug-2024 A-Level students urged to consider pharmaceutical careers Association of the British Pharmaceutical Industry (ABPI)
15-Aug-2024 Prognos Health Empowers Faster, More Targeted Interventions With New Daily HCP Alerts Offering Newswire
15-Aug-2024 Phastar named in 2024 Environment 100 List Phastar